| COVID-19 and angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: what is the evidence? AB Patel, A Verma Jama 323 (18), 1769-1770, 2020 | 576 | 2020 |
| Nasal ACE2 levels and COVID-19 in children AB Patel, A Verma Jama 323 (23), 2386-2387, 2020 | 147 | 2020 |
| Comparing machine learning algorithms for predicting ICU admission and mortality in COVID-19 S Subudhi, A Verma, AB Patel, CC Hardin, MJ Khandekar, H Lee, ... NPJ digital medicine 4 (1), 87, 2021 | 125 | 2021 |
| In silico dynamics of COVID-19 phenotypes for optimizing clinical management C Voutouri, MR Nikmaneshi, CC Hardin, AB Patel, A Verma, ... Proceedings of the National Academy of Sciences 118 (3), e2021642118, 2021 | 44 | 2021 |
| Aldosterone in chronic kidney disease and renal outcomes A Verma, A Vaidya, S Subudhi, SS Waikar European heart journal 43 (38), 3781-3791, 2022 | 42 | 2022 |
| Caring for Dialysis Patients in a Time of COVID-19 A Verma, AB Patel, MC Tio, SS Waikar Kidney Medicine 2 (6), 787-792, 2020 | 32 | 2020 |
| SGLT2 inhibitor: not a traditional diuretic for heart failure A Verma, AB Patel, SS Waikar Cell Metabolism 32 (1), 13-14, 2020 | 32 | 2020 |
| Shedding light on COVID-19: ADAM17 the missing link? B Schreiber, A Patel, A Verma American Journal of Therapeutics 28 (3), e358-e360, 2021 | 31 | 2021 |
| Urinary oxalate as a potential mediator of kidney disease in diabetes mellitus and obesity O Efe, A Verma, SS Waikar Current opinion in nephrology and hypertension 28 (4), 316-320, 2019 | 29 | 2019 |
| Sodium-glucose cotransporter-2 inhibitors (SGLT2i) in kidney transplant recipients: what is the evidence? A Ujjawal, B Schreiber, A Verma Therapeutic Advances in Endocrinology and Metabolism 13, 20420188221090001, 2022 | 25 | 2022 |
| Machine learning applications in nephrology: a bibliometric analysis comparing kidney studies to other medicine subspecialities A Verma, VC Chitalia, SS Waikar, VB Kolachalama Kidney medicine 3 (5), 762-767, 2021 | 22 | 2021 |
| Prognostic machine learning models for COVID‐19 to facilitate decision making S Subudhi, A Verma, AB Patel International Journal of clinical practice 74 (12), e13685, 2020 | 20 | 2020 |
| CREDENCE: significant victory for diabetic kidney disease A Verma, AB Patel, A Upadhyay, SS Waikar Trends in Endocrinology & Metabolism 31 (6), 391-393, 2020 | 12 | 2020 |
| Strategies to minimize heterogeneity and optimize clinical trials in Acute Respiratory Distress Syndrome (ARDS): Insights from mathematical modelling S Subudhi, C Voutouri, CC Hardin, MR Nikmaneshi, AB Patel, A Verma, ... EBioMedicine 75, 2022 | 9 | 2022 |
| DAPA-CKD: Significant Victory for CKD with or without Diabetes AB Patel, K Mistry, A Verma Trends in Endocrinology & Metabolism 32 (6), 335-337, 2021 | 9 | 2021 |
| Associations between kidney histopathologic lesions and incident cardiovascular disease in adults with chronic kidney disease LF Buckley, IM Schmidt, A Verma, R Palsson, D Adam, AM Shah, ... JAMA cardiology 8 (4), 357-365, 2023 | 8 | 2023 |
| Determinants and outcomes associated with urinary calcium excretion in chronic kidney disease J Liu, MC Tio, A Verma, IM Schmidt, TO Ilori, F Knauf, FR Mc Causland, ... The Journal of Clinical Endocrinology & Metabolism 107 (1), e281-e292, 2022 | 8 | 2022 |
| Incidence of hyponatremia in patients with indwelling peritoneal catheters for drainage of malignant ascites S Gupta, MC Tio, ED Gutowski, MS Stecker, A Verma, SS Motwani, ... JAMA Network Open 3 (10), e2017859-e2017859, 2020 | 7 | 2020 |
| Epidemiological study of COVID-19 fatalities and vaccine uptake: insight from a public health database in Ontario, Canada G Leung, A Verma Cureus 13 (7), 2021 | 5 | 2021 |
| Estimating kidney function in patients with cancer: a narrative review SE Claudel, M Gandhi, AB Patel, A Verma Acta Physiologica 238 (2), e13977, 2023 | 4 | 2023 |
Ankit PatelNephrologist, Brigham and Women's Hospital在 partners.org 的电子邮件经过验证
